The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex complicated synthetic process. Initial routes focused on peptide section coupling, utilizing solid-phase https://nicolasrnzt252924.targetblogs.com/41017151/production-and-investigation-applications-of-retatrutide